Zwanenburg E S, Wisselink D D, Klaver C E L, Bilt J D W van der, den Berg J G van, Kodach L L, Nagtegaal I D, Tanis P J, Snaebjornsson P
Department of Surgery, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands.
Virchows Arch. 2025 May 16. doi: 10.1007/s00428-025-04065-x.
The aim of this study was to perform histopathological reassessment of primary resections of locally advanced colon cancer (CC) within a randomized controlled trial, with specific focus on surgical margins and synchronous locoregional peritoneal metastases (SL-PM), and to provide learning points for both surgeons and pathologists. All histopathological slides of patients with c/pT4N0-2M0 or perforated CC included in the COLOPEC trial were reassessed and correlated with surgical reports. The COLOPEC trial originally determined the value of prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC). Frequency of positive margins (R +), R + subtypes, and SL-PM and the association with 5-year peritoneal recurrence were analyzed. Histopathological slides of 199 patients were reassessed. R + was present in 28 patients (14.1%), of which 8 occurred at the site of adhesiolysis (originally classified as pT4a in 6). SL-PM was present in 11 cases (5.5%), of which 9 were not recognized or misclassified. Both R + and SL-PM were associated with 5-year peritoneal metastases in cox regression analysis (HR 2.38, 95% CI 1.12-5.04 and HR 5.98, 95% CI 2.69-13.29, respectively). Of 9 patients with peritoneal recurrences detected during re-exploration at 5-8 weeks after primary tumor resection for intended HIPEC, 5 demonstrated either R + and/or SL-PM. This study brings to light previously unnoticed but clinicopathologically relevant aspects of CC pathology retaining to underdetected SL-PM and new R + types. Underrecognition until now probably relates to the complexity of advanced CC specimens, poor communication between surgeons and pathologists, and the low incidence among high volumes of CC specimens. Trial registration: NCT02231086 (Clinicaltrials.gov).
本研究的目的是在一项随机对照试验中对局部晚期结肠癌(CC)的原发性切除术进行组织病理学重新评估,特别关注手术切缘和同步局部区域腹膜转移(SL-PM),并为外科医生和病理学家提供经验教训。对COLOPEC试验中纳入的c/pT4N0-2M0或穿孔性CC患者的所有组织病理学切片进行重新评估,并与手术报告相关联。COLOPEC试验最初确定了预防性热灌注腹腔化疗(HIPEC)的价值。分析了切缘阳性(R+)的频率、R+亚型、SL-PM以及与5年腹膜复发的关联。对199例患者的组织病理学切片进行了重新评估。28例患者(14.1%)存在R+,其中8例发生在粘连松解部位(6例最初分类为pT4a)。11例(5.5%)存在SL-PM,其中9例未被识别或分类错误。在Cox回归分析中,R+和SL-PM均与5年腹膜转移相关(HR分别为2.38,95%CI为1.12-5.04和HR为5.98,95%CI为2.69-13.29)。在原发性肿瘤切除后5-8周因计划进行HIPEC而再次探查时检测到9例腹膜复发患者,其中5例表现为R+和/或SL-PM。本研究揭示了CC病理学中以前未被注意但临床病理相关的方面,包括未被检测到的SL-PM和新的R+类型。迄今为止未被充分认识可能与晚期CC标本的复杂性、外科医生和病理学家之间沟通不畅以及大量CC标本中发病率低有关。试验注册:NCT02231086(Clinicaltrials.gov)。